A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer

Clinical trial NCT03027284 · COMPLETED

Trial details

NCT number: NCT03027284
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Metastatic Cancer Biliary Tract Carcinoma Cholangiocarcinoma Gall Bladder Carcinoma Solid Tumor Non-Hodgkin's Lymphoma

Start date: 2017-02-03
Primary completion: 2019-06-20
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.